Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, Molrine DC, Perlman S, Picard-Fraser PA, Pollard AJ, Qin C, Subbarao K, Cramer JP. Lambert PH, et al. Among authors: cramer jp. Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25. Vaccine. 2020. PMID: 32507409 Free PMC article.
Developing vaccines against epidemic-prone emerging infectious diseases.
Bernasconi V, Kristiansen PA, Whelan M, Román RG, Bettis A, Yimer SA, Gurry C, Andersen SR, Yeskey D, Mandi H, Kumar A, Holst J, Clark C, Cramer JP, Røttingen JA, Hatchett R, Saville M, Norheim G. Bernasconi V, et al. Among authors: cramer jp. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):65-73. doi: 10.1007/s00103-019-03061-2. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 31776599 Free PMC article. Review.
Correction to: Developing vaccines against epidemic-prone emerging infectious diseases.
Bernasconi V, Kristiansen PA, Whelan M, Román RG, Bettis A, Yimer SA, Gurry C, Andersen SR, Yeskey D, Mandi H, Kumar A, Holst J, Clark C, Cramer JP, Røttingen JA, Hatchett R, Saville M, Norheim G. Bernasconi V, et al. Among authors: cramer jp. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Feb;63(2):226. doi: 10.1007/s00103-019-03085-8. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 31915867 Free PMC article.
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Munoz FM, Cramer JP, Dekker CL, Dudley MZ, Graham BS, Gurwith M, Law B, Perlman S, Polack FP, Spergel JM, Van Braeckel E, Ward BJ, Didierlaurent AM, Lambert PH; Brighton Collaboration Vaccine-associated Enhanced Disease Working Group. Munoz FM, et al. Among authors: cramer jp. Vaccine. 2021 May 21;39(22):3053-3066. doi: 10.1016/j.vaccine.2021.01.055. Epub 2021 Feb 23. Vaccine. 2021. PMID: 33637387 Free PMC article. Review.
SARS-CoV-2 Variants and Vaccines.
Krause PR, Fleming TR, Longini IM, Peto R, Briand S, Heymann DL, Beral V, Snape MD, Rees H, Ropero AM, Balicer RD, Cramer JP, Muñoz-Fontela C, Gruber M, Gaspar R, Singh JA, Subbarao K, Van Kerkhove MD, Swaminathan S, Ryan MJ, Henao-Restrepo AM. Krause PR, et al. Among authors: cramer jp. N Engl J Med. 2021 Jul 8;385(2):179-186. doi: 10.1056/NEJMsr2105280. Epub 2021 Jun 23. N Engl J Med. 2021. PMID: 34161052 Free PMC article.
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
Voss G, Jacquet JM, Tornieporth N, Kampmann B, Karron R, Meulen AS, Chen R, Gruber M, Lurie N, Weller C, Cramer JP, Saville M, Darko M. Voss G, et al. Among authors: cramer jp. Vaccine. 2021 Dec 17;39(51):7357-7362. doi: 10.1016/j.vaccine.2021.10.048. Epub 2021 Nov 17. Vaccine. 2021. PMID: 34799142 Free PMC article.
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.
WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation; Krause PR, Fleming TR, Longini IM, Peto R, Beral V, Bhargava B, Cravioto A, Cramer JP, Ellenberg SS, Figueroa JP, Halloran E, Henao-Restrepo AM, Ryan MJ, Levine MM, Nason M, Nohynek HM, Plotkin S, Rees H, Singh JA, Swaminathan S. WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation, et al. Among authors: cramer jp. N Engl J Med. 2021 Jan 14;384(2):e2. doi: 10.1056/NEJMp2033538. Epub 2020 Dec 2. N Engl J Med. 2021. PMID: 33264543 No abstract available.
Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort.
Antonelli M, Capdevila J, Chaudhari A, Granerod J, Canas LS, Graham MS, Klaser K, Modat M, Molteni E, Murray B, Sudre CH, Davies R, May A, Nguyen LH, Drew DA, Joshi A, Chan AT, Cramer JP, Spector T, Wolf J, Ourselin S, Steves CJ, Loeliger AE. Antonelli M, et al. Among authors: cramer jp. J Infect. 2021 Mar;82(3):384-390. doi: 10.1016/j.jinf.2021.02.015. Epub 2021 Feb 13. J Infect. 2021. PMID: 33592254 Free PMC article.
Delivering Pandemic Vaccines in 100 Days - What Will It Take?
Saville M, Cramer JP, Downham M, Hacker A, Lurie N, Van der Veken L, Whelan M, Hatchett R. Saville M, et al. Among authors: cramer jp. N Engl J Med. 2022 Jul 14;387(2):e3. doi: 10.1056/NEJMp2202669. Epub 2022 Mar 2. N Engl J Med. 2022. PMID: 35249271 No abstract available.
Enabling the evaluation of COVID-19 vaccines with correlates of protection.
Marchant A, Van Damme P, Plotkin S, Neels P, Cassetti MC, Cramer J, Gruber MF, Goldblatt D, King D, Hartig-Merkel W, Vandeputte J. Marchant A, et al. Biologicals. 2024 Feb;85:101723. doi: 10.1016/j.biologicals.2023.101723. Epub 2023 Nov 16. Biologicals. 2024. PMID: 37976940 Free article.
94 results